Skip to main content

Table 3 Outcome of patients

From: Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre

 

Eculizumab group

N = 12 (%)

Control group

N = 14 (%)

Renal response

10 (83)

9 (64)

Partial

8 (66)

6 (43)

complete

2 (17)

3 (21)

eGFR at onset (ml/min/1.73m2)

19 (0–76)

12 (0–31)

eGFR at the end of follow up

45 (0–119)

33 (0–66)

  1. eGFR Estimated glomerular filtration rate. Quantitative values are expressed as median with range
Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us